Table 2.
Patient characteristics | Pre‐excited ECG with symptoms ‐ 30% (108/350) |
Manifest SVT (AVNRT or AVRT) ‐ 70% (242/350) |
P value |
---|---|---|---|
Age | 33±16 | 44±17 | <0.001 |
Women, n (%) | 41% | 71% | <0.001 |
Arrhythmia characteristics | |||
Time between symptoms and ablation (mo), n (IQR) | 36 (12–96) | 72 (24–192) | <0.001 |
Medications before ablation, n (SD) | 0.8±0.9 | 1.4±1.1 | <0.001 |
Electrical cardiovertions, n (SD) | 0.12±0.4 | 0.12±0.4 | 0.95 |
ER evaluations, n (IQR) | 1 (0–3) | 4 (2–10) | <0.001 |
SVT events in the month prior to ablation, n (IQR) | 0 (0–2) | 1 ( 0–2) | 0.16 |
ER indicates emergency department; and SVT, supraventricular tachycardia.